|
TRIAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.99200722162641E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.02735614354788E-12 |
| Normal-vs-Stage2 |
1.838610E-04 |
| Normal-vs-Stage3 |
4.95619999996144E-06 |
| Normal-vs-Stage4 |
8.197500E-03 |
| Stage1-vs-Stage2 |
9.083200E-01 |
| Stage1-vs-Stage3 |
2.064000E-01 |
| Stage1-vs-Stage4 |
1.475360E-01 |
| Stage2-vs-Stage3 |
4.448000E-01 |
| Stage2-vs-Stage4 |
1.758830E-01 |
| Stage3-vs-Stage4 |
2.280600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.99760216648792E-15 |
| Normal-vs-AfricanAmerican |
6.37780050993797E-10 |
| Normal-vs-Asian |
7.053800E-02 |
| Caucasian-vs-AfricanAmerican |
6.307400E-01 |
| Caucasian-vs-Asian |
3.047200E-01 |
| AfricanAmerican-vs-Asian |
3.414400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65223390524716E-12 |
| Normal-vs-Female |
7.97695243193175E-13 |
| Male-vs-Female |
9.930100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.57600000219682E-08 |
| Normal-vs-Extreme_Weight |
2.10800266131628E-11 |
| Normal-vs-Obese |
2.61269994528135E-09 |
| Normal-vs-Extreme_Obese |
2.112300E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.035800E-01 |
| Normal_Weight-vs-Obese |
2.784400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.835800E-01 |
| Extreme_Weight-vs-Obese |
5.007200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.913000E-01 |
| Obese-vs-Extreme_Obese |
7.390000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.351000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.70263803056514E-12 |
| Normal-vs-Age(61-80Yrs) |
4.53859172466764E-13 |
| Normal-vs-Age(81-100Yrs) |
1.241910E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.317500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.287500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.875200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.381000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.364630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.190400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62536650805123E-12 |
| Normal-VS-Type2 PRCC |
4.55060000015273E-07 |
| Normal-VS-KIRP CIMP |
1.101880E-03 |
| Normal-VS-Unclassified PRCC |
9.17659999988274E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.646360E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.781400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.217400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.054050E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.943800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.636500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.12589999989865E-07 |
| Normal-vs-N1 |
1.67479999999554E-05 |
| Normal-vs-N2 |
4.498000E-02 |
| N0-vs-N1 |
3.816200E-02 |
| N0-vs-N2 |
3.636400E-01 |
| N1-vs-N2 |
7.589000E-01 |
|
|
